+86-28-82633987
EN
CN EN

News Center

Release Date:2017/12/27 16:49:37
        CPHI India 2017 is the largest pharmaceutical raw materials exhibition in South Asia. The scope of exhibits mainly includes APIs, intermediates, fine chemicals, etc. Since its first holding in 2006, the exhibition has attracted extensive attention from the world, especially from Chinese api manufacturers and traders, relying on the low threshold and high demand of the Indian pharmaceutical market. The Indian CPHI attracted 1200 + exhibitors, mostly small and medium-sized enterprises. Among them, 40% are from India, 25% are from China, and 10% are from Europe and the United States. There was a large flow of people at the exhibition site, with 25000+ visitors.
       In order to further explore the Indian and Southeast Asian markets, President Xie and President Hu attended the 2017 CPHI India Exhibition on behalf of the company, comprehensively displayed the company's new products and development direction, and conducted in-depth exchanges and communication with new and old customers, laying a good foundation for further cooperation. During the three-day exhibition, an endless stream of customers came to visit and communicate with the company's booth, which further expanded the influence of biopurify brand in the Indian and Southeast Asian markets, achieved good results and achieved the expected results. It has also taken another solid step to accelerate the internationalization process of the "biopurify" brand.
        The following are the pictures of the exhibition site:

















 


 
Prev:The company participated in 2018 Indonesia International Pharmaceutical raw materials exhibition CPHI Next:The company participated in 2017 CPHI exhibition in Frankfurt, Germany